# Adult Healthy Volunteers Study to Evaluate ALPN-101 Safety

> **NCT03748836** · PHASE1 · COMPLETED · sponsor: **Alpine Immune Sciences, Inc.** · enrollment: 96 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ALPN-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03748836
- **Lead sponsor:** Alpine Immune Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-29
- **Primary completion:** 2019-11-18
- **Final completion:** 2019-11-18
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2019-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03748836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03748836, "Adult Healthy Volunteers Study to Evaluate ALPN-101 Safety". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03748836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*